Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients

Life Sciences

Volumn 74, Issue 22, 2004, Pages 2739-2747

  Yamazaki, Hiroshi ^a   Fujieda, Masaki ^a   Togashi, Masahiro ^a   Saito, Tetsuya ^a   Preti, George ^b,c   Cashman, John R ^d   Kamataki, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b MONELL CHEMICAL SENSES CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HUMAN BIOMOLECULAR RESEARCH INSTITUTE   (United States)

Author keywords

Charcoal; Chopper chlorophyllin; Fish like odor syndrome; Flavin containing monooxygenease; Japanese; Trimethylamine; Trimethylamine N oxide; Trimethylaminuria

Indexed keywords

ACTIVATED CARBON; CHLOROPHYLL COPPER COMPLEX; COPPER DERIVATIVE; TRIMETHYLAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; JAPAN; MALE; METABOLIC CAPACITY; METABOLIC DISORDER; METABOLITE; TRIMETHYLAMINUREA; URINARY EXCRETION; URINE LEVEL;

ADULT; CHARCOAL; CHLOROPHYLLIDES; DIET; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; JAPAN; MALE; METABOLISM, INBORN ERRORS; METHYLAMINES; MIDDLE AGED; TREATMENT OUTCOME;

EID: 1642390782     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.022     Document Type: Article

References (26)

1. Akerman B.R., Lemass H., Chow L.M., Lambert D.M., Greenberg C., Bibeau C., Mamer O.A., Treacy E.P. Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort. Molecular Genetics and Metabolism. 68:1999;24-31.
2. Al Waiz M., Ayesh R., Mitchell S.C., Idle J.R., Smith R.L. Trimethylaminuria (fish-odour syndrome): an inborn error of oxidative metabolism. Lancet. 1:1987;634-635.
3. Ayesh R., Mitchell S.C., Zhang A., Smith R.L. The fish odour syndrome: biochemical, familial, and clinical aspects. BMJ. 307:1993;655-657.
4. Cashman J.R. Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism. Pharmacogenomics. 3:2002;325-339.
5. Cashman J.R., Camp K., Fakharzadeh S.S., Fennessey P.V., Hines R.N., Mamer O.A., Mitchell S.C., Preti G., Schlenk D., Smith R.L., Tjoa S.S., Williams D.E., Yannicelli S. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. Current Drug Metabolism. 4:2003;151-170.
6. Cashman J.R., Xiong Y., Lin J., Verhagen H., van Poppel G., Van Bladeren P.J., Larsen-Su S., Williams D.E. In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. Biochemical Pharmacology. 58:1999;1047-1055.
7. Cashman J.R., Zhang J. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation. Drug Metabolism and Disposition. 30:2002;1043-1052.
8. Dashwood R., Yamane S., Larsen R. Study of the forces of stabilizing complexes between chlorophylls and heterocyclic amine mutagens. Environmental and Molecular Mutagenesis. 27:1996;211-218.
9. Federal Register Deodorant drug products for over-the-counter use. Final Monograph. vol. 55 (#92):1990;19862-19865.
10. Fujieda M., Yamazaki H., Togashi M., Saito T., Kamataki T. Two novel single nucleotide polymorphisms (SNPs) of the FMO3 Gene in Japanese. Drug Metabolism and Pharmacokinetics. 18:2003;333-335.
11. Kubota M., Nakamoto Y., Nakayama K., Ujjin P., Satarug S., Mushiroda T., Yokoi T., Funayama M., Kamataki T. A mutation in the flavin-containing monooxygenase 3 gene and its effects on catalytic activity for N-oxidation of trimethylamine in vitro. Drug Metabolism and Pharmacokinetics. 17:2003;207-213.
12. Lattard V., Zhang J., Tran Q., Furnes B., Schlenk D., Cashman J.R. Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies. Drug Metabolism and Disposition. 31:2003;854-860.
13. Lee C.W., Tomlinson B., Yeung J.H., Lin G., Damani L.A. Distribution of the N-oxidation of dietary-derived trimethylamine in a male Chinese population. Pharmacogenetics. 10:2000;829-831.
14. Mitchell S.C. Trimethylaminuria: susceptibility of heterozygotes. Lancet. 354:1999;2164-2165.
15. Mitchell S.C., Smith R.L. Trimethylaminuria: the fish malodor syndrome. Drug Metabolism and Disposition. 29:2001;517-521.
16. Mitchell S.C., Zhang A.Q., Barrett T., Ayesh R., Smith R.L. Studies on the discontinuous N-oxidation of trimethylamine among Jordanian. Ecuadorian and New Guinean populations. Pharmacogenetics. 7:1997;45-50.
17. Preti G., Lawley H.J., Hormann C.A., Cowart B.J., Feldman R.S., Lowry L.D., Young I.-M. Non-oral and Oral Aspects of Oral Malodor. Rosenberg M. Bad Breath: Research Perspectives. 1995;149-173 Tel-Aviv University Press.
18. Suffet I.H., Wable O. Removal of Taste-and-Odor Compounds by Activated Carbon. Advances in Taste-and-Odor: Treatment and Control. 1995;157-208 American Water Works Assoc. Res. Foundation, Denver, CO.
19. Thithapandha A. A pharmacogenetic study of trimethylaminuria in Orientals. Pharmacogenetics. 7:1997;497-501.
20. Tjoa S., Fennessey P. The identification of trimethylamine excess in man: quantitative analysis and biochemical origins. Analytical Biochemistry. 197:1991;77-82.
21. Treacy E., Johnson D., Pitt J.J., Danks D.M. Trimethylaminuria, fish odour syndrome: a new method of detection and response to treatment with metronidazole. Journal of Inherited Metabolic Disease. 18:1995;306-312.
22. Treacy E.P., Akerman B.R., Chow L.M., Youil R., Bibeau C., Lin J., Bruce A.G., Knight M., Danks D.M., Cashman J.R., Forrest S.M. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Human Molecular Genetics. 7:1998;839-845.
23. Zhang A.Q., Mitchell S., Smith R. Fish odour syndrome: verification of carrier detection test. Journal of Inherited Metabolic Disease. 18:1995;669-674.
24. Zhang A.Q., Mitchell S.C., Smith R.L. Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet. 348:1996;1740-1741.
25. Zhang A.Q., Mitchell S.C., Smith R.L. Dietary precursors of trimethylamine in man: a pilot study. Food and Chemical Toxicology. 37:1999;515-520.
26. Zschocke J., Kohlmueller D., Quak E., Meissner T., Hoffmann G.F., Mayatepek E. Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet. 354:1999;834-835.